CLDX
Common StockCelldex Therapeutics, Inc.
Reported Shares
1.1M
Position Mix
No options reported
Reported Value
$36.0M
Portfolio Weight
8.91%
Reported 13F portfolio for Q3 2026.
Reported 13F Portfolio Value
$403.8M
Data Refreshed
Nov 17, 2026
Portfolio Structure
Company profiles & logos by Twelve Data
CLDX
Common StockCelldex Therapeutics, Inc.
Reported Shares
1.1M
Position Mix
No options reported
Reported Value
$36.0M
Portfolio Weight
8.91%
LEGN
Depositary ReceiptLegend Biotech Corp
Reported Shares
1.6M
Position Mix
No options reported
Reported Value
$31.2M
Portfolio Weight
7.73%
SNDX
Common StockSyndax Pharmaceuticals Inc
Reported Shares
1.6M
Position Mix
No options reported
Reported Value
$30.2M
Portfolio Weight
7.47%
COGT
Common StockCogent Biosciences, Inc.
Reported Shares
866.7K
Position Mix
No options reported
Reported Value
$27.8M
Portfolio Weight
6.87%
RLAY
Common StockRelay Therapeutics, Inc.
Reported Shares
1.5M
Position Mix
No options reported
Reported Value
$26.4M
Portfolio Weight
6.55%
AMLX
Common StockAmylyx Pharmaceuticals, Inc.
Reported Shares
894.8K
Position Mix
No options reported
Reported Value
$26.0M
Portfolio Weight
6.45%
VRDN
Common StockViridian Therapeutics, Inc.\DE
Reported Shares
1.2M
Position Mix
No options reported
Reported Value
$25.2M
Portfolio Weight
6.25%
PCVX
Common StockVaxcyte, Inc.
Reported Shares
372.3K
Position Mix
No options reported
Reported Value
$21.2M
Portfolio Weight
5.25%
URGN
Common StockUroGen Pharma Ltd.
Reported Shares
491.1K
Position Mix
No options reported
Reported Value
$20.0M
Portfolio Weight
4.94%
TVTX
Common StockTravere Therapeutics, Inc.
Reported Shares
322.6K
Position Mix
No options reported
Reported Value
$19.0M
Portfolio Weight
4.70%
CGEM
Common StockCullinan Therapeutics, Inc.
Reported Shares
962.8K
Position Mix
No options reported
Reported Value
$14.8M
Portfolio Weight
3.66%
PHVS
Common StockPharvaris N.V.
Reported Shares
455.8K
Position Mix
No options reported
Reported Value
$14.5M
Portfolio Weight
3.58%
VERA
Common StockVera Therapeutics, Inc.
Reported Shares
436.5K
Position Mix
No options reported
Reported Value
$14.1M
Portfolio Weight
3.49%
CTMX
Common StockCytomX Therapeutics, Inc.
Reported Shares
4.6M
Position Mix
No options reported
Reported Value
$12.4M
Portfolio Weight
3.06%
BEAM
Common StockBeam Therapeutics Inc.
Reported Shares
476.3K
Position Mix
No options reported
Reported Value
$11.6M
Portfolio Weight
2.88%
NRIX
Common StockNurix Therapeutics, Inc.
Reported Shares
460K
Position Mix
No options reported
Reported Value
$10.9M
Portfolio Weight
2.70%
SMMT
Common StockSummit Therapeutics Inc.
Reported Shares
493.8K
Position Mix
No options reported
Reported Value
$8.4M
Portfolio Weight
2.07%
UTHR
Common StockUNITED THERAPEUTICS Corp
Reported Shares
15K
Position Mix
No options reported
Reported Value
$8.1M
Portfolio Weight
2.01%
IMCR
Depositary ReceiptImmunocore Holdings plc
Reported Shares
256.1K
Position Mix
No options reported
Reported Value
$7.8M
Portfolio Weight
1.92%
KRYS
Common StockKrystal Biotech, Inc.
Reported Shares
22K
Position Mix
No options reported
Reported Value
$7.3M
Portfolio Weight
1.81%